Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Ophthalmology. 2015 Aug 20;122(10):1967–1975. doi: 10.1016/j.ophtha.2015.06.042

Figure 6.

Figure 6

Distribution of vitreous haze grades over time in (A) the fluocinolone acetonide (implant) and (B) systemic therapy (systemic) groups in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. N=number of eyes.